Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
Clinical trial NCT02850406 · TERMINATED
Trial details
- NCT number
- NCT02850406
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-05
- Primary completion
- 2023-10-02
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.